Glucose

Glucose is an intravenous solution for injection containing the active ingredient glucose. It is supplied without a specific brand name, with an unspecified strength, and is classified as an excipient used in parenteral nutrition. Marketed in the European Union, this Rx product provides a direct source of carbohydrate energy when administered through the bloodstream.

Glucose injection is employed in clinical settings to address several metabolic and fluid needs. It is commonly used for:

- Treating hypoglycemia by rapidly raising blood glucose levels. - Supplying calories in parenteral nutrition for patients unable to eat orally. - Supporting fluid replacement when combined with electrolytes. - Providing an energy substrate during surgery or intensive care. - Assisting in diagnostic glucose tolerance testing when required.

Glucose administered intravenously can produce a range of reactions, most of which are mild and transient. Awareness of both common and serious effects helps clinicians monitor patients appropriately.

Common: - Transient hyperglycemia. - Local irritation or pain at the injection site. - Mild nausea or vomiting. - Headache. - Temporary electrolyte imbalance.

Serious: - Severe hyperglycemia leading to osmotic diuresis. - Hypotension due to rapid infusion. - Allergic reaction or anaphylaxis (rare). - Hyperosmolar hyperglycemic state in susceptible individuals.

When using intravenous glucose, several safety considerations should be observed to minimize risk. Healthcare providers should:

- Verify patient blood glucose levels before and during infusion. - Adjust infusion rate to avoid rapid spikes in plasma glucose. - Monitor electrolytes, especially potassium and sodium, during prolonged therapy. - Use caution in patients with diabetes, renal impairment, or heart failure. - Ensure proper aseptic technique to prevent infection. - Document any adverse reactions promptly.

Glucose solutions can interact with other medications or clinical conditions, influencing therapy outcomes. Consider the following guidance:

Avoid: - Co-administration with high-dose insulin without monitoring, which may cause severe hypoglycemia. - Simultaneous infusion of hypertonic dextrose with certain diuretics that may exacerbate electrolyte loss.

Use with caution: - Concurrent use of corticosteroids, which can increase blood glucose levels. - Administration alongside beta‑adrenergic agonists that may raise glucose concentrations. - Patients receiving total parenteral nutrition containing other carbohydrate sources. - Situations involving renal or hepatic dysfunction, requiring dose adjustments.